We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

News

News

Equity Win for Promethean Particles Marks BioCity Success

Promethean Particles secures £500,000 investment funding.
News

Promise of Structure-Based Drug Design for GPCRs

Heptares Therapeutics announces the recent publication of a major review of the state of the art for GPCR drug discovery and new insights that, for the first time, can be obtained from structural biology.
News

BioCryst Provides Corporate Update

BioCryst Pharmaceuticals, Inc. announces financial results for the first quarter ended March 31, 2012.
News

BioTek Expands Asia Pacific Office

BioTek Instruments, Inc., continues their commitment to the Asia Pacific region with the expansion of their Singapore office.
News

Greenphire and Merge Healthcare Form Exclusive Partnership

Partnership to integrate clinical payment and EDC platforms.
News

New Muscular Dystrophy Treatment Approach Developed Using Human Stem Cells

New process makes the production of human muscle cells from stem cells efficient and effective.
News

Prosonix to Present at RDD 2012 and ATS 2012 International Conference

Prosonix will present a poster entitled ‘Engineered Combination Respiratory Medicines for Localized Drug Delivery’ at RDD.
News

Plexpress and SBW Partner to Offer TRAC Gene Expression Analysis

CRO adds TRAC to service portfolio for pre-clinical ADME-Tox studies.
News

Mesoblast Receives FDA Clearance for Phase 2 Clinical Trial of Proprietary Stem Cell Therapy in Type 2 Diabetes

Trial will be randomized, placebo-controlled to evaluate safety and effectiveness over 3 months of a single intravenous injection of one of three progressively increasing MPC doses in 60 Type 2 diabetes patients with elevated blood glucose levels.
News

Pliaglis Receives Positive Opinion from the BfArM in the E.U.

Enters national licensing phase in 17 E.U. countries.
Advertisement